Viewing Study NCT05841420

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-06-21 @ 4:18 AM
Study NCT ID: NCT05841420
Status: RECRUITING
Last Update Posted: 2025-01-29
First Post: 2023-03-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer
Sponsor: Morten Ladekarl
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreas Cancer View
None Non-Resectable Pancreas Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fragile View
None Elderly View
None Palliative View